Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86762575 | 8676257 | 5 | F | 20140915 | 20160808 | 20120720 | 20160816 | EXP | US-ASTRAZENECA-2011SE62059 | ASTRAZENECA | 22364.00 | DY | F | Y | 89.80000 | KG | 20160817 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86762575 | 8676257 | 1 | PS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 25 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 86762575 | 8676257 | 2 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | TWO PILLS IN THE MORNING AND TWO PILLS AT NIGHT | 19962 | MODIFIED-RELEASE TABLET | |||||||||
| 86762575 | 8676257 | 3 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 50 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 86762575 | 8676257 | 4 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 100 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 86762575 | 8676257 | 5 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | ADDITIONAL PUFF OF SYMBICORT, UNKNOWN UNKNOWN | 21929 | ||||||||||
| 86762575 | 8676257 | 6 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5UG,TWO TIMES A DAY UNKNOWN | 21929 | ||||||||||
| 86762575 | 8676257 | 7 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 86762575 | 8676257 | 8 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 86762575 | 8676257 | 9 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 86762575 | 8676257 | 10 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 86762575 | 8676257 | 11 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 325 | MG | QD | ||||||||
| 86762575 | 8676257 | 12 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 86762575 | 8676257 | 13 | C | TRILIPIX | FENOFIBRIC ACID | 1 | Oral | 0 | 135 | MG | QD | ||||||||
| 86762575 | 8676257 | 14 | C | NITRO | NITROGLYCERIN | 1 | Sublingual | 0.4MG UNKNOWN | 0 | .4 | MG | ||||||||
| 86762575 | 8676257 | 15 | C | HYDROCODONE | HYDROCODONE | 1 | Oral | 5/325 MG FOUR TIMES A DAY AS NEEDED | 0 | ||||||||||
| 86762575 | 8676257 | 16 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 800 MG TWICE A DAY BUT TAKES IT DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 86762575 | 8676257 | 1 | Hypertension |
| 86762575 | 8676257 | 2 | Hypertension |
| 86762575 | 8676257 | 3 | Hypertension |
| 86762575 | 8676257 | 4 | Hypertension |
| 86762575 | 8676257 | 5 | Dyspnoea |
| 86762575 | 8676257 | 6 | Dyspnoea |
| 86762575 | 8676257 | 7 | Myocardial infarction |
| 86762575 | 8676257 | 8 | Blood cholesterol increased |
| 86762575 | 8676257 | 9 | Stent placement |
| 86762575 | 8676257 | 10 | Myocardial infarction |
| 86762575 | 8676257 | 11 | Myocardial infarction |
| 86762575 | 8676257 | 12 | Myocardial infarction |
| 86762575 | 8676257 | 13 | Blood triglycerides |
| 86762575 | 8676257 | 14 | Chest pain |
| 86762575 | 8676257 | 15 | Pain |
| 86762575 | 8676257 | 16 | Inflammation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 86762575 | 8676257 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 86762575 | 8676257 | Body height decreased | |
| 86762575 | 8676257 | Chest discomfort | |
| 86762575 | 8676257 | Chest pain | |
| 86762575 | 8676257 | Drug dose omission | |
| 86762575 | 8676257 | Drug ineffective | |
| 86762575 | 8676257 | Dyspnoea | |
| 86762575 | 8676257 | Flushing | |
| 86762575 | 8676257 | Headache | |
| 86762575 | 8676257 | Hyperhidrosis | |
| 86762575 | 8676257 | Inflammation | |
| 86762575 | 8676257 | Insomnia | |
| 86762575 | 8676257 | Intentional product use issue | |
| 86762575 | 8676257 | Memory impairment | |
| 86762575 | 8676257 | Nervousness | |
| 86762575 | 8676257 | Pain | |
| 86762575 | 8676257 | Palpitations | |
| 86762575 | 8676257 | Peripheral swelling | |
| 86762575 | 8676257 | Stress | |
| 86762575 | 8676257 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 86762575 | 8676257 | 3 | 2012 | 0 | ||
| 86762575 | 8676257 | 14 | 20160421 | 0 |